Bayer Contests Generics' Loss Claims In Xarelto Patent Fight
Bayer has accused several generic-drug makers of overstating the profits they lost when a judge in London told them to stop selling their own versions of blood thinner Xarelto to avoid...To view the full article, register now.
Already a subscriber? Click here to view full article